Delix Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 21-50 Employees

Delix Therapeutics revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$417,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$32,000,000
Total funding	$36,145,000

Key Contacts at Delix Therapeutics

Mark Rus

Chief Executive Officer & Director

Alison Mungenast

Senior Director, Neuroplasticity

Rajiv Agrawal

Associate Director, Pharmacology

Milan Chytil

Senior Director Of Medicinal Chemistry

Manuka Ghosh

Associate Director

Company overview

Headquarters	Cambridge, Massachusetts, United States
Website	delixtherapeutics.com
NAICS	541714
Founded	2019
Employees	21-50
Socials

Delix Therapeutics Email Formats

Delix Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@delixtherapeutics.com), used 80% of the time.

Format	Example	Percentage
{first initial}	j@delixtherapeutics.com	80%
{first name}	john@delixtherapeutics.com	20%

About Delix Therapeutics

Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

Delix Therapeutics has 12 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Delix Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2022-02-10	12	$10,000,000
2024-01-13	9	$320,000
2024-07-04	9	$825,000
2025-10-10	1	$25,000,000

Funding Insights

$36,145,000

Total funding amount

$25,000,000

Most recent funding amount

Number of funding rounds

Delix Therapeutics Tech Stack

Discover the technologies and tools that power Delix Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Prismic

CMS

Open Graph

Miscellaneous

Vimeo

Video players

React

JavaScript frameworks

Heroku

PaaS

PWA

Miscellaneous

Gatsby

JavaScript frameworks

Webpack

Miscellaneous

Microsoft 365

Frequently asked questions

Delix Therapeutics is located in Cambridge, Massachusetts, US.

Delix Therapeutics generates an estimated annual revenue of $10,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Delix Therapeutics has an estimated valuation of $32,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Delix Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Delix Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Delix Therapeutics has raised a total of $36,145,000 across 4 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Delix Therapeutics

Mark Rus

Chief Executive Officer & Director

Alison Mungenast

Senior Director, Neuroplasticity

Rajiv Agrawal

Associate Director, Pharmacology

Milan Chytil

Senior Director Of Medicinal Chemistry

Manuka Ghosh

Associate Director

4.8